Topline data were announced from a phase 3 trial evaluating ersodetug in patients aged 3 months to 45 years with congenital hyperinsulinism.
Candidate selection underscores Confo’s ability to rapidly advance differentiated GPCR-targeting therapeutics and its focus ...
Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned ...
MBX Biosciences Inc. (NASDAQ:MBX) is one of the stocks that will double in 2026. On December 4, Goldman Sachs initiated ...
TwistedSifter on MSN
Pregnant woman relies on emergency snacks for hypoglycemia, but her greedy husband keeps eating them
The post Pregnant Woman Relies On Emergency Snacks For Hypoglycemia, But Her Greedy Husband Keeps Eating Them first on ...
Earlier on November 25, Evercore ISI initiated coverage of DexCom with an In Line rating and $68 price target. While ...
Nearly two-thirds of VA nursing home residents with hypoglycemia also had hyperglycemia, study finds
About two-thirds of Veterans Affairs nursing homes residents with hypoglycemia also had hyperglycemia, according to a December study published in the Journal of the American Geriatrics Society.
Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.
Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...
Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results